Skip to main content
. 2023 Mar 1;55(3):487–501. doi: 10.1038/s12276-023-00944-y

Fig. 3. Dysregulation of m6A-modified ncRNAs in human cancer.

Fig. 3

GBM glioblastoma multiforme, ESCC esophageal squamous cell carcinoma, LSCC laryngeal squamous cell carcinoma, HNSCC head and neck squamous cell carcinoma, UT urinary tract, RCC renal cell carcinoma, BC bladder cancer, PC prostate cancer, LC lung cancer, NSCLC non-small cell lung cancer, LUAD lung adenocarcinoma, HCC hepatocellular carcinoma, PAC pancreatic cancer, TET thymic epithelial tumor, OS osteosarcoma, HT hematological system, CML chronic myeloid leukemia, TLBL T-cell lymphoblastic lymphoma, DLBCL diffuse large B-cell lymphoma, CRC colorectal cancer, GNC genital system, EEC endometrioid endometrial carcinoma, EOC epithelial ovarian cancer, CC cervical cancer, GC gastric cancer, BRC breast cancer, TC thyroid cancer, NPC nasopharyngeal carcinogenesis.